ETRM Insider Trading Activity and SEC Form 4 Filings
ETRM insider trading summary
No open-market insider purchases or sales of EnteroMedics Inc (ETRM) have been reported on SEC Form 4 in the past 12 months.
Latest ETRM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 25, 2017 | Carl Goldfischer | Director | Sell | $470 (97 @ $4.85) |
| May 25, 2017 | Carl Goldfischer | Director | Sell | $22K (4,571 @ $4.85) |
| Jun 3, 2016 | Peter M. DeLange | SVP, Ops & Bus Dev | Buy | $11K (20,000 @ $0.55) |
| Nov 12, 2015 | Mark B Knudson | Chrmn, Pres & CEO | Buy | $50K (310,000 @ $0.16) |
| Nov 12, 2015 | Dan W Gladney | Chief Executive Officer | Buy | $135K (750,000 @ $0.18) |
| Aug 13, 2015 | Mark B Knudson | Chrmn, Pres & CEO | Buy | $42K (168,000 @ $0.25) |
| Aug 12, 2015 | Mark B Knudson | Chrmn, Pres & CEO | Buy | $33K (135,000 @ $0.24) |
| May 16, 2015 | Dan W Gladney | Chief Executive Officer | Buy | $61K (84,745 @ $0.72) |
| Jun 19, 2014 | Cathy Friedman | Director | Buy | $20K (11,800 @ $1.70) |
| Jan 8, 2014 | Luke Evnin | Director | Sell | $711K (284,531 @ $2.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.